Soluble tumour necrosis factor receptor release after anti-CD3 monoclonal antibody treatment in mice is independent of tumour necrosis factor-alpha release. [electronic resource]
- European cytokine network Dec 1996
- 751-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't